EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Natural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X‐Linked Adrenoleukodystrophy

Julia Lier iD, Markus Ponleitner, Denny Popp, Lisa Schäfer, Franziska Küstermann, Christof Meigen, Frank Kratzer, Joachim Janda iD, Jürgen Okun, Rami Abou Jamra, Wolfgang Köhler, Caroline Bergner iD

Journal of Inherited Metabolic Disease · 2026

DOI: 10.1002/jimd.70176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Julia Lier und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center, Leipzig, Germany. Hauptthemen laut MEDLINE: Adrenoleukodystrophy, Fatty Acids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine Leipzig, Clinician Scientist Programme, Deutsche Forschungsgemeinschaft, Sächsische Aufbaubank.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

X‐linked adrenoleukodystrophy (X‐ALD) is a rare monogenic disorder characterized by marked variability in clinical presentation, age at onset, and disease progression. A deeper understanding of its natural history and the relationship between biochemical markers and clinical phenotypes is essential for improving disease monitoring, patient counseling, and optimizing clinical trial design. In particular, the predictive value of very long‐chain fatty acids (VLCFA) for clinical phenotypes has recently garnered increased attention. In this longitudinal, mixed prospective/retrospective, single‐center study, we analyzed clinical and biochemical data from 364 patients with X‐ALD (255 males). Parameters included clinical scores (EDSS, AACS), age at symptom onset, and disease manifestations, which were correlated with individual VLCFA levels. Patients with adrenal insufficiency (AI) exhibited significantly elevated VLCFA concentrations. Higher C26:0 levels were associated with faster progression (measured by EDSS); however, effect sizes were small and inter‐individual variability considerable. Although initial symptom severity was comparable between sexes, males presented earlier and progressed faster. Among patients seen in early clinical stages (EDSS ≤ 4.5), disease progression rates were higher (males: 0.34 ± 0.77; females: 0.11 ± 0.11) than in those presenting at more advanced stages (EDSS > 4.5; males: 0.23 ± 0.33; females: 0.09 ± 0.10). We provide comprehensive data on the prevalence of disease manifestations and the natural course of X‐ALD in a large adult cohort. The observed association between elevated VLCFA levels and adrenal insufficiency should be considered in future clinical monitoring and trial design. However, due to the small effect sizes and variability, VLCFA levels offer limited prognostic utility for individual patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdrenoleukodystrophyFatty AcidsHumansMalePhenotypeFemaleAdultDisease ProgressionBiomarkersLongitudinal StudiesAdolescentRetrospective StudiesYoung AdultProspective StudiesMiddle AgedAge of OnsetAdrenal Insufficiency

Stichwörter der Autor:innen

data registryleukodystrophynatural historyx‐ALD

Substanzen

BiomarkersFatty Acids

Autor:innen und Institutionen

  • Department of Neurology, University Medical Center, Leipzig, Germany.
  • Department of Neurology, Medical University of Vienna; Comprehensive Center for Clinical Neurosciences and Mental Health, Vienna, Austria.
  • Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Saxony, Germany.
  • LIFE Leipzig Research Center for Civilization Diseases, Leipzig University, Leipzig, Germany.
  • German Center for Child and Adolescent Health (DZKJ), Partner Site Leipzig/Dresden, Leipzig, Germany.
  • Division of Neuropediatrics and Metabolic Medicine, Department of Pediatrics I, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

ORCID-Profile: Julia Lier, Joachim Janda, Caroline Bergner

Förderung

  • Faculty of Medicine Leipzig, Clinician Scientist Programme
  • Deutsche Forschungsgemeinschaft
  • Sächsische Aufbaubank
  • Bundesministerium für Gesundheit

Zitieren

APA

Lier, J., Ponleitner, M., Popp, D., Schäfer, L., Küstermann, F., Meigen, C., Kratzer, F., Janda, J., Okun, J., Jamra, R. A., Köhler, W., & Bergner, C. (2026). Natural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X‐Linked Adrenoleukodystrophy. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70176

Vancouver

Lier J, Ponleitner M, Popp D, Schäfer L, Küstermann F, Meigen C, et al. Natural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X‐Linked Adrenoleukodystrophy. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70176

BibTeX
@article{Lier2026,
  author = {Lier, Julia and Ponleitner, Markus and Popp, Denny and Schäfer, Lisa and Küstermann, Franziska and Meigen, Christof and Kratzer, Frank and Janda, Joachim and Okun, Jürgen and Jamra, Rami Abou and Köhler, Wolfgang and Bergner, Caroline},
  title = {Natural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X‐Linked Adrenoleukodystrophy},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  doi = {10.1002/jimd.70176}
}
Kostenlos starten →